Earnings Results
Q32 Bio Inc. (NASDAQ:QTTB) is scheduled to report its Q2 earnings results on August 05, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-0.56, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $600.0K, up from a year ago.
Company Overview
The stock currently trades at $16.23 with a market capitalization of $39.2M.
Ahead of Q32 Bio Inc.'s earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Q32 Bio Inc. should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.
Q32 Bio Inc. Earnings History
| Quarter | EPS Actual | EPS Est. | Surprise |
| Q1 (May 2026) | $-0.54 | $-0.65 | +16.9% |
| Q4 (Mar 2026) | $3.65 | $-0.85 | +529.4% |
Related Tools: Earnings Calendar | View QTTB Stock Page
Frequently Asked Questions
When does Q32 Bio Inc. report earnings?
Check the latest earnings dates on our QTTB earnings page or the Earnings Calendar.
Did QTTB beat earnings estimates?
See the full Q2 results including EPS actual vs estimate on our QTTB earnings page.